Need Public Policy for Human Gene Editing, Heatwaves, or Asteroids? Try Thinking Like a Citizen
By Nicholas Weller, Michelle Sullivan Govani, Mahmud Farooque,
Issues in Science and Technology
| 05. 19. 2021
In a ballroom at the Arizona Science Center one afternoon in 2017, more than 70 Phoenix residents—students, teachers, nurses, and retirees—gathered around tables to participate in a public forum about how cities can respond to extreme weather such as heat waves. Each table was covered in colorful printouts with a large laminated poster resembling a board game. Milling between the tables were decisionmakers from local government and the state. All were taking part in a deliberative process called participatory technology assessment, or pTA, designed to break down the walls between “experts” and citizens to gain insights into public policy dilemmas involving science, technology, and uncertainty.
Foreshadowing their varied viewpoints and experiences, participants prepared differently for the “extreme weather” of the heavily air conditioned ballroom, with some gripping cardigans around their shoulders while others were comfortable in tank tops. Extreme heat is something all the participants were familiar with—Phoenix is one of the hottest cities in the country—but not everyone understood the unequal way that heat and related deaths affect different parts of the Valley of the Sun. Though a...
Related Articles
By Matt Novak, Gizmodo | 07.23.2025
Robert F. Kennedy Jr., the Secretary of Health and Human Services, has made a big push to get agencies like the Food and Drug Administration to use generative artificial intelligence tools. In fact, Kennedy recently told Tucker Carlson that AI...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...